Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BELLUS-Q

K-Number: K253344 · 2025-11-25

Decision Date2025-11-25
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

BELLUS-Q is a medical device manufactured by Speclipse, Inc.. It received FDA 510(k) clearance on 2025-11-25 under approval number K253344. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BELLUS-Q?

BELLUS-Q is a medical device that received FDA 510(k) clearance on 2025-11-25. It is manufactured by Speclipse, Inc.. The 510(k) number is K253344.

When was BELLUS-Q approved by the FDA?

BELLUS-Q received FDA 510(k) clearance on 2025-11-25, under approval number K253344.

What company makes BELLUS-Q?

BELLUS-Q is manufactured by Speclipse, Inc..

What is the FDA product code for BELLUS-Q?

The FDA product code for BELLUS-Q is GEX. This falls under the Gastroenterology category.

Other Devices by Speclipse, Inc.

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.